Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4027-56-9

Post Buying Request

4027-56-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4027-56-9 Usage

General Description

5-methyl-1H-pyrazole-3-carboxamide, also known as 5MPY, is a chemical compound with the molecular formula C5H7N3O. It is a pyrazole derivative, which is a group of nitrogen-containing aromatic heterocyclic compounds. 5MPY is commonly used as a building block in the synthesis of various pharmaceuticals and agrochemicals due to its versatile reactivity. It has also been studied for its potential applications in coordination chemistry and as a ligand for metal-catalyzed reactions. Additionally, 5MPY has been evaluated for its antiviral and anticancer activities, making it a compound of interest in the field of medicinal chemistry. Overall, 5MPY is a valuable chemical used in various industries for its reactivity and potential biological activities.

Check Digit Verification of cas no

The CAS Registry Mumber 4027-56-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,0,2 and 7 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 4027-56:
(6*4)+(5*0)+(4*2)+(3*7)+(2*5)+(1*6)=69
69 % 10 = 9
So 4027-56-9 is a valid CAS Registry Number.

4027-56-9Relevant articles and documents

In Silico Evaluation of the Binding Site of Fucosyltransferase 8 and First Attempts to Synthesize an Inhibitor with Drug-Like Properties

Strecker, Claas,Baerenfaenger, Melissa,Miehe, Michaela,Spillner, Edzard,Meyer, Bernd

, p. 1923 - 1931 (2020)

Core fucosylation of N-glycans is catalyzed by fucosyltransferase 8 and is associated with various types of cancer. Most reported fucosyltransferase inhibitors contain non-drug-like features, such as charged groups. New starting points for the development of inhibitors of fucosyltransferase 8 using a fragment-based strategy are presented. Firstly, we discuss the potential of a new putative binding site of fucosyltransferase 8 that, according to a molecular dynamics (MD) simulation, is made accessible by a significant motion of the SH3 domain. This might enable the design of completely new inhibitor types for fucosyltransferase 8. Secondly, we have performed a docking study targeting the donor binding site of fucosyltransferase 8, and this yielded two fragments that were linked and trimmed in silico. The resulting ligand was synthesized. Saturation transfer difference (STD) NMR confirmed binding of the ligand featuring a pyrazole core that mimics the guanine moiety. This ligand represents the first low-molecular-weight compound for the development of inhibitors of fucosyltransferase 8 with drug-like properties.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4027-56-9